Inside JNJ’s Medical Device Business: Developments, Future Growth PART 1 OF 8
Medical Devices 3Q17 performance
In 3Q17, Johnson & Johnson (JNJ) reported ~$19.7 billion in sales. The companys Medical Devices business generated ~33.5% of the total sales, amounting to ~$6.6 billion.
The segments sales rose ~7.1%, on a YoY (year-over-year) basis. On an operational basis, the segments sales rose ~6.6% in 3Q17.
JNJ acquired TearScience, a vision care services company, and completed the divestiture of Codman Neuro in 3Q17…
Read the full article at: http://marketrealist.com/2017/11/jnjs-medical-devices-business-progressing-amid-ongoing-restructuring-efforts/